Wolfram syndrome: Clinical and genetic aspects

Research output: Contribution to journalArticle

6 Citations (Scopus)

Abstract

Wolfram syndrome, also known as DIDMOAD syndrome, was first described in 1938. It consists of a combination of diabetes insipidus, diabetes mellitus, optic atrophy, and deafness. A large number of other abnormalities also may develop, such as dilation of the urinary tract, neurologic disease, and psychiatric illness. These conditions are discovered during childhood and early adulthood, are progressive, and are often fatal. Pathologic studies confirm the neurodegenerative nature of the syndrome. Wolfram syndrome patients appear to be relatively resistant to the microvascular changes usually seen in diabetes. Several other endocrine disorders, particularly hypogonadism, have been reported. Significant advances have been made in the genetics of Wolfram syndrome. Although the syndrome is inherited in an autosomal recessive fashion, deletions of the mitochondrial genome have been detected in some patients. Recent progress has revealed mutations of a gene on chromosome 4p16 in Wolfram syndrome patients. This gene has been named WFS1 and encodes a transmembrane protein of unknown function. The relationship between the nuclear DNA mutations and those of the mitochondria is not clear, but it is the subject of future study.

Original languageEnglish
Pages (from-to)51-59
Number of pages9
JournalEndocrinologist
Volume10
Issue number1
StatePublished - 2000

Fingerprint

Wolfram Syndrome
Urologic Diseases
Mutation
Mitochondrial Genome
Hypogonadism
Nervous System Diseases
Genes
Psychiatry
Dilatation
Mitochondria
Chromosomes
DNA

ASJC Scopus subject areas

  • Endocrinology

Cite this

Wolfram syndrome : Clinical and genetic aspects. / Fuqua, John.

In: Endocrinologist, Vol. 10, No. 1, 2000, p. 51-59.

Research output: Contribution to journalArticle

@article{91b6eb3e66074676862bda8caa6ca45a,
title = "Wolfram syndrome: Clinical and genetic aspects",
abstract = "Wolfram syndrome, also known as DIDMOAD syndrome, was first described in 1938. It consists of a combination of diabetes insipidus, diabetes mellitus, optic atrophy, and deafness. A large number of other abnormalities also may develop, such as dilation of the urinary tract, neurologic disease, and psychiatric illness. These conditions are discovered during childhood and early adulthood, are progressive, and are often fatal. Pathologic studies confirm the neurodegenerative nature of the syndrome. Wolfram syndrome patients appear to be relatively resistant to the microvascular changes usually seen in diabetes. Several other endocrine disorders, particularly hypogonadism, have been reported. Significant advances have been made in the genetics of Wolfram syndrome. Although the syndrome is inherited in an autosomal recessive fashion, deletions of the mitochondrial genome have been detected in some patients. Recent progress has revealed mutations of a gene on chromosome 4p16 in Wolfram syndrome patients. This gene has been named WFS1 and encodes a transmembrane protein of unknown function. The relationship between the nuclear DNA mutations and those of the mitochondria is not clear, but it is the subject of future study.",
author = "John Fuqua",
year = "2000",
language = "English",
volume = "10",
pages = "51--59",
journal = "Endocrinologist",
issn = "1051-2144",
publisher = "Lippincott Williams and Wilkins",
number = "1",

}

TY - JOUR

T1 - Wolfram syndrome

T2 - Clinical and genetic aspects

AU - Fuqua, John

PY - 2000

Y1 - 2000

N2 - Wolfram syndrome, also known as DIDMOAD syndrome, was first described in 1938. It consists of a combination of diabetes insipidus, diabetes mellitus, optic atrophy, and deafness. A large number of other abnormalities also may develop, such as dilation of the urinary tract, neurologic disease, and psychiatric illness. These conditions are discovered during childhood and early adulthood, are progressive, and are often fatal. Pathologic studies confirm the neurodegenerative nature of the syndrome. Wolfram syndrome patients appear to be relatively resistant to the microvascular changes usually seen in diabetes. Several other endocrine disorders, particularly hypogonadism, have been reported. Significant advances have been made in the genetics of Wolfram syndrome. Although the syndrome is inherited in an autosomal recessive fashion, deletions of the mitochondrial genome have been detected in some patients. Recent progress has revealed mutations of a gene on chromosome 4p16 in Wolfram syndrome patients. This gene has been named WFS1 and encodes a transmembrane protein of unknown function. The relationship between the nuclear DNA mutations and those of the mitochondria is not clear, but it is the subject of future study.

AB - Wolfram syndrome, also known as DIDMOAD syndrome, was first described in 1938. It consists of a combination of diabetes insipidus, diabetes mellitus, optic atrophy, and deafness. A large number of other abnormalities also may develop, such as dilation of the urinary tract, neurologic disease, and psychiatric illness. These conditions are discovered during childhood and early adulthood, are progressive, and are often fatal. Pathologic studies confirm the neurodegenerative nature of the syndrome. Wolfram syndrome patients appear to be relatively resistant to the microvascular changes usually seen in diabetes. Several other endocrine disorders, particularly hypogonadism, have been reported. Significant advances have been made in the genetics of Wolfram syndrome. Although the syndrome is inherited in an autosomal recessive fashion, deletions of the mitochondrial genome have been detected in some patients. Recent progress has revealed mutations of a gene on chromosome 4p16 in Wolfram syndrome patients. This gene has been named WFS1 and encodes a transmembrane protein of unknown function. The relationship between the nuclear DNA mutations and those of the mitochondria is not clear, but it is the subject of future study.

UR - http://www.scopus.com/inward/record.url?scp=0033950726&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0033950726&partnerID=8YFLogxK

M3 - Article

AN - SCOPUS:0033950726

VL - 10

SP - 51

EP - 59

JO - Endocrinologist

JF - Endocrinologist

SN - 1051-2144

IS - 1

ER -